Register   |   Log In Contact Us
Or login with one of the following

Log in

 

Prostate Cancer

Cognitive existential couple therapy (CECT) in men and partners facing localised prostate cancer: A randomised controlled trial - Abstract

OBJECTIVES: To assess the efficacy of cognitive existential couple therapy (CECT) for relationship function, coping, cancer distress and mental health in men with localised prostate cancer and in their partners.

Read more ...

Supportive care for men with prostate cancer: Why are the trials not working? A systematic review and recommendations for future trials - Abstract

Men with prostate cancer are likely to have a long illness and experience psychological distress for which supportive care may be helpful.

Read more ...

Prognostic utility of PET in prostate cancer - Abstract

Many standard nonimaging-based prediction tools exist for prostate cancer.

Read more ...

Can subepididymal orchiectomy re-emerge as the treatment of choice in patients with advanced prostatic carcinoma? - Abstract

To study the effectiveness of bilateral subepididymal orchiectomy compared to bilateral simple and subcapsular orchiectomy in terms of androgen ablation, control of disease progression and esthetic superiority.

Read more ...

Comparison of three different techniques of low-dose-rate seed implantation for prostate cancer - Abstract

PURPOSE: Three different techniques of low-dose-rate seed implantation for prostate cancer have been used since its use started in our hospital.

Read more ...

Dose painting to treat single-lobe prostate cancer with hypofractionated high-dose radiation using targeted external beam radiation: Is it feasible? - Abstract

Targeted focal therapy strategies for treating single-lobe prostate cancer are under investigation.

Read more ...

BPH: A tell-tale sign of prostate cancer? Results from the Prostate Cancer and Environment Study (PROtEuS) - Abstract

INTRODUCTION: In a population-based case-control study (PROtEuS), we examined the association between prostate cancer (PCa) and (1) benign prostatic hypertrophy (BPH) history at any time prior to PCa diagnosis, (2) BPH-history reported at least 1 year prior to interview/diagnosis (index date) and (3) exposure to BPH-medications.

Read more ...

Prostate biopsy core handling: Comparison of contemporary preembedding methods - Abstract

INTRODUCTION: The probability of prostate cancer detection is related to the amount of tissue represented.

Read more ...

Evaluation of biochemical recurrence-free survival after radical prostatectomy by cancer of the prostate risk assessment post-surgical (CAPRA-S) Score - Abstract

BACKGROUND: The cancer of the prostate risk assessment (CAPRA) score has been defined to predict prostate cancer recurrence based on the pre-clinical data, then pathological data have also been incorporated.

Read more ...

Prostate cancer: Assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRI - Abstract

PURPOSE: To investigate the effects of androgen-deprivation therapy (ADT) on MRI parameters and evaluate their associations with treatment response measures.

Read more ...